Table 5.
Variant | OR | Sensitivity | Specificity | PPV | NPV | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CI | CI | CI | CI | CI | |||||||
PSSM2/MFM‐WB | P2 | 2.07 | 0.82‐5.12 | 0.27 | 0.18‐0.38 | 0.85 | 0.73‐0.92 | 0.69 | 0.50‐0.84 | 0.48 | 0.38‐0.58 |
P3 | 1.31 | 0.43‐3.75 | 0.12 | 0.06‐0.23 | 0.91 | 0.80‐0.96 | 0.62 | 0.36‐0.82 | 0.45 | 0.36‐0.54 | |
P4 | 1.35 | 0.56‐3.36 | 0.24 | 0.15‐0.34 | 0.82 | 0.69‐0.90 | 0.62 | 0.43‐0.78 | 0.46 | 0.36‐0.56 | |
PSSM2/MFM‐AR | P2 | 2.00 | 0.60‐7.05 | 0.33 | 0.19‐0.51 | 0.80 | 0.63‐0.90 | 0.63 | 0.39‐0.82 | 0.55 | 0.40‐0.68 |
P3 | 1.00 | 0.05‐19.6 | 0.03 | 0.002‐0.17 | 0.97 | 0.83‐0.99 | 0.50 | 0.03‐0.98 | 0.50 | 0.38‐0.63 | |
P4 | 1.62 | 0.45‐5.56 | 0.20 | 0.09‐0.37 | 0.87 | 0.70‐0.95 | 0.60 | 0.31‐0.83 | 0.52 | 0.39‐0.65 |
None of the calculated values reached statistical significance (P < .05).
Abbreviations: AR, Arabian; MFM, Myofibrillar Myopathy; NPV, negative predictive value; PPV, positive predictive value; PSSM2, Polysaccharide storage myopathy type 2; WB, Warmblood.